Distinguished leaders from fields including healthcare, law, entertainment, hospitality, and more make up our Board of Directors. While diverse in their areas of expertise, all of our members are united in their passion to advance ovarian and related gynecologic cancer research, help guide our path forward, and contribute toward our goal of finding a cure.
Emeritus Executive Committee Member
Emeritus Executive Committee Member
Live webinar on March 25 will explore gynecologic clear cell carcinoma research, treatment, and survivorship Ovarian Cancer Research Alliance (OCRA) invites you to join our upcoming Ask the Experts webinar focused on gynecologic clear cell carcinoma, a rare subtype of gynecologic cancer. This live, interactive session will feature gynecologic oncologist Aaron Praiss, MD, who will discuss current research, treatment … Continued
This article was updated in February 2026 to reflect NCCN’s release of the 2026 Guidelines for Cervical Cancer Patients. OCRA is a proud sponsor of the 2026 Patient Guidelines for Cervical Cancer, and the 2025 Patient Guidelines for Ovarian, and Uterine Cancer. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful … Continued
$1 million global research award, plus an additional $1 million in compute support, advances AI-driven efforts to personalize ovarian cancer care The Global Ovarian Cancer Research Consortium today awarded its inaugural AI Accelerator Grant to an international team of researchers to examine whether artificial intelligence (AI) can improve how survival and treatment response are predicted … Continued
Get email updates about research news, action alerts, and ways to join the fight.
